Peptide record

TPDB21561

Antibacterial Anticancer Antifungal Toxicity modified_plain modified
14 source-reported length (unverified)
Basic Information
TPDB21561
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CAFPdb dbAMP
modified_plain
Yes
A modified multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide record curated from Peptipedia, CAFPdb, and dbAMP, without an available 3D structural model. Source-reported length: 14 (unverified).
Modified, details unspecified
Sequence
INLKKLAKLXKKIS

Source notation is retained verbatim; residue notation and chemical identity have not been independently validated. The displayed length is source-reported and unverified.

Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
14 source-reported length (unverified)
Evidence Records 3 records
Evidence 1 Activity

Activity

50% Cytotoxicity
Toxicity
>32 µg/mL
Cytotoxic
50% Cytotoxicity | >32 | µg/mL | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14. | Peptides | 2018
Evidence 2 Activity

Activity

14.5-15.5% Cytotoxicity
Toxicity
32 µg/mL
Cytotoxic
14.5-15.5% Cytotoxicity | 32 | µg/mL | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14. | Peptides | 2018
Evidence 3 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Peptides. 2018 Mar 101:95-105.